Skip to content
The Policy VaultThe Policy Vault

Ambien CR (zolpidem)Blue Cross Blue Shield of New Mexico

insomnia (quantity limit criteria)

Initial criteria

  • Quantity limit for the Target Agent(s) will be approved when ONE of the following is met:
  • 1. The requested quantity (dose) does NOT exceed the program quantity limit OR
  • 2. The requested quantity (dose) exceeds the program quantity limit AND BOTH of the following:
  • A. ONE of the following:
  • 1. BOTH of the following:
  • A. The requested agent does NOT have a maximum FDA labeled dose for the requested indication AND
  • B. There is support for therapy with a higher dose for the requested indication OR
  • 2. BOTH of the following:
  • A. The requested quantity (dose) does NOT exceed the maximum FDA labeled dose for the requested indication AND
  • B. There is support for why the requested quantity (dose) cannot be achieved with a lower quantity of a higher strength that does NOT exceed the program quantity limit OR
  • 3. BOTH of the following:
  • A. The requested quantity (dose) exceeds the maximum FDA labeled dose for the requested indication AND
  • B. There is support for therapy with a higher dose for the requested indication AND
  • B. ONE of the following:
  • 1. The patient is using one insomnia agent OR
  • 2. BOTH of the following:
  • A. The patient is using TWO insomnia agents AND
  • B. The previous insomnia agent will be discontinued and replaced by the requested agent

Approval duration

12 months